Immunovant (IMVT) PT Raised to Street High $60 at Citi, Remains Top Pick
Tweet Send to a Friend
Citi analyst Samantha Semenkow raised the price target on Immunovant (NASDAQ: IMVT) to Street High $60.00 (from $51.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
